CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 161 filers reported holding CHINA BIOLOGIC PRODS INC in Q3 2016. The put-call ratio across all filers is 1.47 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $6,985,000 | +5.0% | 65,700 | +13.1% | 0.08% | -7.1% |
Q1 2016 | $6,651,000 | -16.0% | 58,100 | +4.5% | 0.08% | -15.8% |
Q4 2015 | $7,921,000 | +94.7% | 55,600 | +22.7% | 0.10% | +90.6% |
Q3 2015 | $4,069,000 | -17.4% | 45,300 | +5.8% | 0.05% | -1.9% |
Q2 2015 | $4,929,000 | +58.3% | 42,800 | +31.3% | 0.05% | +63.6% |
Q1 2015 | $3,114,000 | – | 32,600 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SPQ Asia Capital Ltd | 287,277 | $35,760,000 | 28.32% |
WARBURG PINCUS LLC | 6,674 | $830,780,000 | 13.45% |
Ariose Capital Management Ltd | 238,841 | $27,689,000 | 7.56% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 12,600 | $1,568,000 | 4.48% |
RUDMAN ERROL M | 37,001 | $4,606,000 | 3.72% |
INDUS CAPITAL PARTNERS, LLC | 245,237 | $30,527,000 | 2.89% |
Ativo Capital Management LLC | 93,784 | $11,674,000 | 2.70% |
OBERWEIS ASSET MANAGEMENT INC/ | 63,305 | $7,880,000 | 2.27% |
Point72 Hong Kong Ltd | 31,500 | $3,921,000 | 2.14% |
Cormorant Asset Management, LP | 112,867 | $14,050,000 | 1.55% |